BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31385317)

  • 1. Prevalence of Babesia in Canadian blood donors: June-October 2018.
    Tonnetti L; O'Brien SF; Grégoire Y; Proctor MC; Drews SJ; Delage G; Fearon MA; Brès V; Linnen JM; Stramer SL
    Transfusion; 2019 Oct; 59(10):3171-3176. PubMed ID: 31385317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of Babesia microti infection in Canadian blood donors.
    O'Brien SF; Delage G; Scalia V; Lindsay R; Bernier F; Dubuc S; Germain M; Pilot G; Yi QL; Fearon MA
    Transfusion; 2016 Jan; 56(1):237-43. PubMed ID: 26426217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Babesia microti in the U.S. Blood Supply.
    Moritz ED; Winton CS; Tonnetti L; Townsend RL; Berardi VP; Hewins ME; Weeks KE; Dodd RY; Stramer SL
    N Engl J Med; 2016 Dec; 375(23):2236-2245. PubMed ID: 27959685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description of 15 DNA-positive and antibody-negative "window-period" blood donations identified during prospective screening for Babesia microti.
    Moritz ED; Tonnetti L; Hewins ME; Berardi VP; Dodd RY; Stramer SL
    Transfusion; 2017 Jul; 57(7):1781-1786. PubMed ID: 28453188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of transfusion-transmitted Babesia microti, American Red Cross 2010-2017.
    Tonnetti L; Townsend RL; Dodd RY; Stramer SL
    Transfusion; 2019 Sep; 59(9):2908-2912. PubMed ID: 31250463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Babesia microti seroprevalence in Minnesota blood donors.
    Tonnetti L; Thorp AM; Deisting B; Bachowski G; Johnson ST; Wey AR; Hodges JS; Leiby DA; Mair D
    Transfusion; 2013 Aug; 53(8):1698-705. PubMed ID: 23145838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microti.
    Leiby DA; Chung AP; Gill JE; Houghton RL; Persing DH; Badon S; Cable RG
    Transfusion; 2005 Nov; 45(11):1804-10. PubMed ID: 16271108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lookback investigations of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area.
    Johnson ST; Cable RG; Leiby DA
    Transfusion; 2012 Jul; 52(7):1509-16. PubMed ID: 21910741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of Babesia microti in blood donors from Babesia-endemic areas of the northeastern United States: 2000 through 2007.
    Johnson ST; Cable RG; Tonnetti L; Spencer B; Rios J; Leiby DA
    Transfusion; 2009 Dec; 49(12):2574-82. PubMed ID: 19821951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of Babesia microti blood donation screening.
    Tonnetti L; Townsend RL; Deisting BM; Haynes JM; Dodd RY; Stramer SL
    Transfusion; 2019 Feb; 59(2):593-600. PubMed ID: 30499595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence for widespread Babesia microti transmission in Australia.
    Faddy HM; Rooks KM; Irwin PJ; Viennet E; Paparini A; Seed CR; Stramer SL; Harley RJ; Chan HT; Dennington PM; Flower RLP
    Transfusion; 2019 Jul; 59(7):2368-2374. PubMed ID: 31070793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of transfusion-transmitted Babesia microti in Canada.
    O'Brien SF; Drews SJ; Yi QL; Bloch EM; Ogden NH; Koffi JK; Lindsay LR; Gregoire Y; Delage G
    Transfusion; 2021 Oct; 61(10):2958-2968. PubMed ID: 34272882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Babesia microti real-time polymerase chain reaction testing of Connecticut blood donors: potential implications for screening algorithms.
    Johnson ST; Van Tassell ER; Tonnetti L; Cable RG; Berardi VP; Leiby DA
    Transfusion; 2013 Nov; 53(11):2644-9. PubMed ID: 23445322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Babesia microti-specific immunodominant epitopes and development of a peptide EIA for detection of antibodies in serum.
    Houghton RL; Homer MJ; Reynolds LD; Sleath PR; Lodes MJ; Berardi V; Leiby DA; Persing DH
    Transfusion; 2002 Nov; 42(11):1488-96. PubMed ID: 12421223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Babesia microti in Individuals with Lyme Disease.
    Curcio SR; Tria LP; Gucwa AL
    Vector Borne Zoonotic Dis; 2016 Dec; 16(12):737-743. PubMed ID: 27911694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Babesia blood testing: the first-year experience.
    Tonnetti L; Dodd RY; Foster G; Stramer SL
    Transfusion; 2022 Jan; 62(1):135-142. PubMed ID: 34726279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay.
    Levin AE; Williamson PC; Erwin JL; Cyrus S; Bloch EM; Shaz BH; Kessler D; Telford SR; Krause PJ; Wormser GP; Ni X; Wang H; Krueger NX; Caglioti S; Busch MP
    Transfusion; 2014 Sep; 54(9):2237-44. PubMed ID: 24995863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-transmitted Babesia microti identified through hemovigilance.
    Tonnetti L; Eder AF; Dy B; Kennedy J; Pisciotto P; Benjamin RJ; Leiby DA
    Transfusion; 2009 Dec; 49(12):2557-63. PubMed ID: 19624607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot serosurvey of Babesia microti in Chinese blood donors.
    Bloch EM; Yang Y; He M; Tonnetti L; Liu Y; Wang J; Guo Y; Li H; Leiby DA; Shan H;
    Vox Sang; 2018 May; 113(4):345-349. PubMed ID: 29582438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period.
    Herwaldt BL; Neitzel DF; Gorlin JB; Jensen KA; Perry EH; Peglow WR; Slemenda SB; Won KY; Nace EK; Pieniazek NJ; Wilson M
    Transfusion; 2002 Sep; 42(9):1154-8. PubMed ID: 12430672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.